BIOMAT Database Logo BIOMAT Database Logo

[Electrophysiological effects of prostaglandin E2 in dysfunction of sinus node]. 2002

K M Koshumbaeva, and M T Tulenov, and Z G Kim

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001146 Arrhythmia, Sinus Irregular HEART RATE caused by abnormal function of the SINOATRIAL NODE. It is characterized by a greater than 10% change between the maximum and the minimum sinus cycle length or 120 milliseconds. Sinus Arrhythmia,Arrhythmia, Sinoatrial,Sinoatrial Arrhythmia,Arrhythmias, Sinoatrial,Arrhythmias, Sinus,Sinoatrial Arrhythmias,Sinus Arrhythmias

Related Publications

K M Koshumbaeva, and M T Tulenov, and Z G Kim
[The electrophysiological effects of digitalis in sinus node dysfunction].
January 1978, Bollettino della Societa italiana di cardiologia,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological effects of diphenylhydantoin in patients with sinus node dysfunction.
March 1986, Japanese heart journal,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological effects of propranolol in patients with sinus node dysfunction.
May 1988, Japanese heart journal,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction.
July 1982, Japanese circulation journal,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological effects of glucose-insulin-potassium on sinus node function in patients with and without sinus node dysfunction.
October 1982, Cardiovascular research,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological effects of ethmozin on sinus nodal function in patients with and without sinus node dysfunction.
March 1984, European heart journal,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological effects of mexiletine in patients of sinus node dysfunction and intraventricular conduction defects.
January 1986, Indian heart journal,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological features in patients with sinus node dysfunction and vasovagal syncope.
December 2011, Archives of medical science : AMS,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
October 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
K M Koshumbaeva, and M T Tulenov, and Z G Kim
Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction.
September 1976, Circulation,
Copied contents to your clipboard!